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Abstract 
 
Dopaminergic hyperfunction and N-methyl-D-aspartate receptor (NMDAR) 
hypofunction have both been implicated in psychosis. Dopamine-releasing drugs and 
NMDAR antagonists replicate symptoms associated with psychosis in healthy 
humans and exacerbate symptoms in patients with schizophrenia. Though 
hippocampal dysfunction contributes to psychosis, the impact of NMDAR 
hypofunction on hippocampal plasticity remains poorly understood. Here, we used 
an NMDAR antagonist rodent model of psychosis to investigate hippocampal long-
term potentiation (LTP). We found that single systemic NMDAR antagonism results 
in a region-specific, presynaptic LTP at hippocampal CA1-subiculum synapses that 
is induced by activation of D1/D5 dopamine receptors and modulated by L-type 
voltage-gated Ca2+ channels. Thereby, our findings may provide a cellular 
mechanism how NMDAR antagonism can lead to an enhanced hippocampal output 
causing activation of the hippocampus-ventral tegmental area-loop and overdrive of 
the dopamine system. 
 
 
 
 
 
 
 
 
 
 3
Introduction 
 
Pathophysiological concepts of psychosis are based on dysregulated dopaminergic 
neurotransmission due to two fundamental observations: First, stimulants which 
enhance dopaminergic transmission (e.g. cocaine or amphetamines) can lead to 
psychosis resembling positive symptoms of schizophrenia (Lieberman et al, 1987). 
Second, currently used antipsychotics block dopamine (DA) receptors (Creese et al, 
1976). In contrast to dopaminergic agents, antagonists of the glutamatergic NMDA 
receptor (NMDAR) like phencyclidine, ketamine and MK-801 can replicate not only 
positive, but also negative and cognitive symptoms associated with psychosis in 
healthy humans. Moreover, they exacerbate symptoms in patients with 
schizophrenia (Luby et al, 1959). Consequently, psychosis was linked to NMDAR 
hypofunction (Javitt and Zukin, 1991; Olney et al, 1999) and contemporary models of 
psychosis stress interactions between the glutamatergic and the dopaminergic 
neurotransmitter systems (Lisman et al, 2008). NMDAR antagonists can increase the 
release of DA in various cortical and subcortical brain regions (Breier et al, 1998; 
Deutch et al, 1987; Whitton et al, 1992). Dopaminergic fibers arising from the ventral 
tegmental area (VTA) form a functional loop with the hippocampus, in particular with 
the CA1 and the subiculum (SUB) (Verney et al, 1985). Both hippocampal regions 
project to the nucleus accumbens, which regulates the release of DA in the 
hippocampus by disinhibition of the VTA (Brudzynski and Gibson, 1997; Floresco et 
al, 2001). Interestingly, experimental findings suggest a close functional relationship 
between memory formation in the hippocampus and dopaminergic neuromodulation 
(Lisman and Grace, 2005). Activation of D1/D5 DA receptors (D1/D5R) lowers the 
threshold for the induction of long-term potentiation (LTP), a cellular correlate for 
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memory formation, in CA1 and the SUB both in vitro and in vivo (Li et al, 2003; 
Otmakhova and Lisman, 1996; Roggenhofer et al, 2010, 2013). Aside from transient 
immediate psychosis-like effects, acute treatment with the NMDAR antagonist MK-
801 induces lasting effects on hippocampal function and synaptic plasticity 
(Wiescholleck and Manahan-Vaughan, 2013). In fact, dysregulation in the interplay 
of NMDAR function and dopaminergic neuromodulation may underlie hippocampus-
dependent deficits. Hence, single NMDAR antagonist administration in rodents 
represents a feasible approach to characterize the impact of temporary systemic 
hypoglutamatergic and hyperdopaminergic states on LTP in the hippocampus. Here, 
we report that after systemic NMDAR antagonism and in the drug-withdrawn state, 
CA1-SUB synapses show a region-specific, presynaptic LTP that is induced by 
D1/D5R. Thus, our results link the concepts of NMDAR hypofunction and 
dopaminergic hyperfunction, and potentially provide a cellular mechanism for 
hippocampal dysfunction after acute psychotic states. 
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Materials and Methods 
 
Please refer to Supplementary Materials and Methods for additional information. 
 
Animals: All procedures were performed in accordance to national and international 
guidelines and approved by local authorities. Male Wistar rats (4-6 weeks old) 
received a single intraperitoneal injection with either MK-801 ((5S,10R)-(+)-5-methyl-
10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine maleate, 5 mg/kg body 
weight, except for the experiment shown in Fig. S1b: 0.5 mg/kg, dissolved in 0.9% 
saline) or 0.9% saline (10 ml/kg body weight). 
Electrophysiology: Single-cell recordings were performed in horizontal hippocampal 
slices prepared as described (Wozny et al, 2008a, 2008b). To study synaptic 
plasticity at glutamatergic synapses, all experiments were performed in the presence 
of bicuculline (5 µM) to block GABAA receptor-mediated responses. Drugs were 
bath-applied except for BAPTA (30 mM in the intracellular solution). Afferent 
stimulation (Fig. S1a) was adjusted to give comparably sized evoked excitatory 
postsynaptic potentials/currents (EPSP/EPSC, ~30% of maximal amplitude, Table 
S1). EPSP/EPSCs were normalized to baseline values. LTP was calculated by 
averaging the responses collected during the last 5 min of each experiment. 
Miniature EPSCs (mEPSC) were recorded in the presence of tetrodotoxin (1 µM) 
and bicuculline (10 µM). 
Histology: Postfixed slices containing a biocytin-labeled subicular pyramidal cell were 
immunohistochemically stained against D1R, D5R and vGluT1 and assessed by 
confocal microscopy. 
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Quantification of subicular DA levels: DA was measured by high performance liquid 
chromatography (HPLC) with electrochemical detection after extraction to alumina as 
previously described (Felice et al, 1978). 
Ca2+ imaging: Imaging of stimulus-induced (20 pulses at 20 Hz) changes in Ca2+ 
fluorescence in the subicular field was performed in acute slices stained with the AM-
ester form of Oregon Green 488 BAPTA-1 under submerged conditions. In order to 
dissect presynaptic Ca2+ signals, postsynaptic glutamatergic and GABAergic 
transmission was blocked with D-AP5 (50 µM), CNQX (30 µM), (RS)-MCPG (150 
µM), bicuculline (10 µM) and CGP 55845 (20 µM) (Fig. S7). D1/D5Rs were activated 
by the agonist SKF38393 (100 µM) alone or in combination with nifedipine (20 µM). 
Changes in fluorescence over time in the subicular field were plotted as ∆F/F0 with 
F0 representing the average fluorescence before stimulus onset. For analysis of 
stimulus-induced changes in presynaptic calcium fluorescence, the peak ∆F/F0 in 
regions of interest, excluding cell bodies of neurons and glia, was calculated. 
Statistical analysis: Values are given as mean±SEM unless otherwise stated. 
Comparisons between two groups were analyzed by appropriate t-tests, 
nonparametric equivalents or Kolmogorov-Smirnov test. Multigroup comparisons 
were analyzed with one-way ANOVA or Kruskal-Wallis H-test followed by Dunnett’s 
or Dunn’s post-hoc test. 
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Results 
 
LTP following systemic NMDAR antagonism 
We first tested for LTP at Schaffer collateral (SC)-CA1 and CA1-SUB synapses 
using strong high-frequency stimulation (HFS, 4x 100 pulses at 100 Hz, 10 s inter-
train interval). In line with previous findings (Wöhrl et al, 2007), LTP at SC-CA1 
synapses was impaired in MK-801-treated rats 24 hours post injection (control: 
1.69±0.11, n=8, p<0.001; MK-801: 1.11±0.11, n=8, Fig. 1a, c). In sharp contrast, LTP 
could be readily induced at CA1-SUB synapses (control: 2.23±0.30, n=11, p<0.01; 
MK-801: 2.58±0.49, n=9, p<0.05, Fig. 1d, f). Since strong HFS protocols can mask 
an altered threshold to induce LTP, we dampened the stimulation protocol to 10 
pulses at 40 Hz. This attenuated HFS protocol failed to induce plasticity in CA1 and 
subicular pyramidal cells in control rats (CA1: 1.15±0.09, n=7, SUB: 1.08±0.07, 
n=10, Fig. 1b, c, e, f). In MK-801 treated rats, however, it resulted in a robust late-
onset LTP exclusively in the SUB (CA1: 1.10±0.07, n=7, SUB: 2.73±0.36, n=9, 
p<0.001, Fig. 1b, c, e, f). Comparing injection of 0.5 mg/kg and 5 mg/kg of MK-801 
showed no significant difference in LTP (0.5 mg: 2.12±0.38, n=7, p<0.05; 5 mg: 
2.73±0.36, n=9, p<0.001, Fig. S1b). We also tested this attenuated stimulation 
protocol in granule cells of the dentate gyrus (DG) and CA3 pyramidal cells. Like in 
the CA1, HFS failed to induce LTP in the DG and CA3 (control: DG: 1.14±0.18, n=6, 
CA3: 1.34±0.19, n=5; MK-801: DG: 1.12±0.12, n=8, CA3: 1.38±0.19, n=5, Fig. S1d-
f). Thus, we conclude that this form of LTP is unique to subicular neurons. 
To identify how fast this subicular LTP appears following MK-801 injection and 
whether changes in plasticity are permanent, we also investigated LTP induction one 
hour, one and two weeks after systemic application of MK-801. Stable LTP could be 
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induced one hour after MK-801 treatment and one week but not two weeks after 
application (one hour: 2.31±0.49, n=6, p<0.05; one week: 2.24±0.40, n=8, p<0.05; 
two weeks: 1.08±0.09, n=13, Fig. S1c). 
 
At various synapses in the central nervous system, LTP depends on NMDAR 
activation (Nicoll and Malenka, 1999). In the presence of the NMDAR antagonist 
AP5, HFS resulted in a different time course of LTP lacking the initial enhancement 
(2.20±0.22, n=9 vs. 1.46±0.07, n=7, p<0.05 at min 10-15, Fig. 2a). Yet, late-onset 
LTP still emerged in subicular pyramidal cells from MK-801-treated animals 
(3.43±0.53, n=7, p<0.01 at min 35-40, Fig. 2a). This suggests that this form of late-
onset LTP consist of an NMDAR-dependent and an NMDAR-independent 
component. 
NMDAR-independent LTP has been reported to depend on the activation of 
metabotropic glutamate receptors (mGluR) (O’Leary and O’Connor, 1999). But, 
MCPG, an antagonist of mGluR I/II, did not prevent LTP in cells from MK-801-treated 
rats (2.51±0.56, n=8, p<0.05, Fig. S2). 
 
LTP in MK-801-treated rats depends on the activation of D1/D5Rs 
Next, we tested if the LTP in MK-801-treated rats is mediated by endogenous DA 
released upon HFS. Using HPLC, we detected endogenous DA concentration in 
subicular tissue samples in both animal groups (control: 23.99±4.72 pg/mg wet 
tissue, n=8; MK-801-treated animals: 20.65±2.29 pg/mg wet tissue, n=8, Fig. S3). 
When D2 dopamine receptors (D2R), targeted by many commonly used 
antipsychotics, were blocked with the antagonist sulpiride, LTP could still be induced 
(2.11±0.21, n=9, p<0.001, Fig. 2b). However, the specific D1/D5R antagonist 
 9
SCH23390 blocked LTP (0.98±0.10, n=8, Fig. 2c). Baseline EPSP amplitudes were 
not affected by D1/D5R blockade (1.06±0.09, n=6, Fig. 2e). Up to this point it 
remained unclear whether activation of D1/D5Rs is mandatory for the induction or 
expression of this late-onset LTP. Therefore, we blocked D1/D5Rs with SCH23390 
after applying electrical HFS. Under these conditions, we still observed a robust LTP 
concluding that D1/D5R activation is crucial for the induction, but not the expression 
of this form of LTP (2.61±0.61, n=7, p<0.05, Fig. 2d). Analysis of synaptic responses 
during 40 Hz stimulation revealed a more pronounced short-term depression when 
D1/D5Rs were blocked (Fig. 2f, g, Fig. S6). This result suggests that under 
conditions of sustained synaptic activity, rapid replenishment of the readily 
releasable pool of synaptic vesicle seems to be facilitated by tonic D1/D5R activation 
in MK-801-treated rats. 
If D1/D5R activation is mandatory for the LTP in MK-801-treated rats, activating 
these receptors by a specific agonist should also result in LTP. Accordingly, bath-
application of the specific D1/D5R agonist SKF38393 at various concentrations 
enhanced synaptic transmission in MK-801-treated rats (10 µM: 1.44±0.12, n=8, 
p<0.05; 30 µM: 1.39±0.10, n=7, p<0.01, Fig. 2h), but not in control slices (10 µM: 
1.00±0.07, n=6, 30 µM: 1.04±0.08, n=9, Fig. 2h). To determine the expression site of 
this D1/D5R-mediated chemical enhancement of synaptic transmission in MK-801-
treated animals, we analyzed the paired-pulse index (PPI). The PPI investigates the 
ability of synapses to increase transmitter release upon the second of two closely 
spaced afferent stimuli, and depends on residual Ca2+ levels in the presynaptic 
terminal (Zucker and Regehr, 2002). The PPI decreased after D1/D5R activation 
consistent with a presynaptic expression mechanism of this enhanced synaptic 
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transmission in MK-801-treated rats (10 µM: from 1.50±0.17 to 1.26±0.13, n=8, 
p<0.05, 30 µM: from 1.65±0.18 to 1.21±0.09, n=7, p<0.05, Fig. 2i). 
 
LTP in MK-801-treated rats is expressed presynaptically and is independent of 
postsynaptic Ca2+ 
We used different approaches to determine the site of HFS-induced LTP in MK-801-
treated animals. The PPI decreased from 2.33±0.29 to 1.74±0.18 after LTP induction 
consistent with a presynaptic expression mechanism (n=9, p<0.05, Fig. 3a). 
Additionally, we studied failure rates of minimal stimulation. LTP expression reduced 
failure rates from 71±4% to 30±9% (n=9, p<0.01, Fig. 3b), indicating an increase in 
transmitter release probability. 
Changes in the coefficient of variation (CV)-index that accompany alterations in 
synaptic efficacy are likewise used to differentiate between pre- and postsynaptic 
mechanisms (Faber and Korn, 1991). Supporting a presynaptic mechanism, LTP 
induction went along with changes in the CV-index (baseline: 0.058±0.017, LTP: 
0.023±0.007, n=9, p<0.05, Fig. S4). 
To determine whether postsynaptic Ca2+ signaling is required for the LTP in MK-801-
treated rats, we performed whole-cell patch-clamp recordings to ensure proper 
dialysis of cells with a Ca2+ buffer. We first reproduced the LTP in MK-801-treated 
animals under patch-clamp conditions and therefore adjusted the HFS to 200 pulses 
at 50 Hz applied in current-clamp mode. This resulted in a robust LTP in MK-801-
treated rats (1.41±0.06, n=7, p<0.001, Fig. 3c), but only brief post-tetanic 
potentiation and no LTP in control animals (1.00±0.08, n=8, Fig. 3c). The magnitude 
of LTP in whole-cell patch-clamp recordings was smaller than in sharp 
microelectrode recordings, a fact that might be attributed to a difference in oxygen 
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supply under submerged and interface recording conditions (Hájos et al, 2009). 
Postsynaptic Ca2+ buffering with the fast Ca2+ chelator BAPTA did not prevent LTP 
induction in MK-801-treated rats (1.29±0.06, n=8, p<0.01, Fig. 3c), suggesting that 
LTP is independent of postsynaptic Ca2+ signaling. 
 
D1/D5Rs modulate release probability of glutamate in MK-801-treated rats 
Confocal imaging of biocytin-filled (postsynaptic marker) subicular bursting neurons 
in slices that were immunohistochemically labeled for vGluT1 (presynaptic marker) 
and D1R or D5R suggested the existence of pre- and postsynaptic D1Rs and D5Rs 
(Fig. 4a, b). All DA receptors are coupled to G-proteins. In general, activation of G-
protein signaling pathways has been shown to modulate action potential-
independent mEPSCs directly (Scanziani et al, 1992). Given a tonic basal activation 
of D1/D5Rs by endogenous DA, functional presynaptic D1/D5R could modulate 
transmitter release independent of action potential-triggered calcium influx (Bouron 
and Reuter, 1999). Therefore, we measured mEPSCs before and after the 
application of the specific D1/D5R antagonist SCH23390. 
Only in MK-801-treated rats, D1/D5R blockade reduced mEPSC frequency without 
affecting the amplitudes (mEPSC frequency: control: 0.85±0.17 Hz during baseline, 
0.83±0.13 Hz during SCH23390; MK-801: 0.99±0.19 Hz during baseline, 0.61±0.11 
Hz during SCH23390, p<0.05; mEPSC amplitude: control: 16.12±0.99 pA during 
baseline, 16.28±0.94 pA during SCH23390; MK-801: 16.55±1.36 pA during baseline, 
15.98±1.56 pA during SCH23390, n=8 in both animal groups, Fig. 4c-f). These 
results support the existence of functional D1/D5Rs located at the presynaptic site of 
the CA1-SUB synapse and indicate that activation of D1/D5Rs by endogenous DA 
tonically maintains glutamate release at CA1-SUB synapses in MK-801-treated rats. 
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LTP in MK-801-treated rats is mediated by the adenylate cyclase (AC)-cAMP-
PKA signaling cascade 
D1/D5R are positively coupled to the AC-cAMP-PKA signaling cascade (Missale et 
al, 1998). We studied whether blocking this pathway prevents the LTP in MK-801-
treated animals. Indeed, preincubation of slices with the PKA inhibitor Rp-8-CPT-
cAMPS blocked the induction of LTP in MK-801-treated animals (1.19±0.14, n=6, 
Fig. 5a). To test for differences in pathway function downstream of the D1/D5R 
between control and MK-801-treated rats, we activated the AC-cAMP-PKA cascade 
with forskolin. In line with a cAMP-mediated form of LTP, forskolin enhanced EPSC 
amplitudes. As we did not find differences between both animal groups (control: 
1.62±0.20, n=6, p<0.05; MK-801: 1.63±0.20, n=6, p<0.05, Fig. 5b) alterations 
upstream of the AC-cAMP-PKA cascade have to be considered. 
 
LTP in MK-801-treated rats is modulated by L-type voltage-gated Ca2+ channels 
DA receptor activation can modulate L-type voltage-gated Ca2+ channel (LTCC) 
function via PKA-dependent phosphorylation of the α1 subunit of LTCCs and a 
subsequent increase of Ca2+ currents (Missale et al, 1998; Surmeier et al, 1995). 
Blocking LTCCs with nifedipine did not affect baseline EPSP amplitudes (1.01±0.09, 
n=7, Fig. S5a) but caused a substantial attenuation of LTP in MK-801-treated rats 
(1.49±0.08, n=9, p<0.001, Fig. 5c). Notably, applying nifedipine after HFS likewise 
attenuated LTP (1.52±0.16, n=9, p<0.05, Fig. 5d). Bath-application of diltiazem, a 
structurally different inhibitor of LTCC, also attenuated LTP (1.23±0.09, n=5, p<0.05, 
Fig. S5b). Thus, LTCCs seem to contribute to LTP expression in MK-801-treated 
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rats. Noteworthy, in control animals, NMDAR-dependent subicular LTP is not LTCC-
dependent (1.98±0.30, n=5, p<0.05, Fig. S5c). 
To test for altered presynaptic LTCC function in MK-801-treated animals, we 
recorded stimulus-induced changes in Ca2+ fluorescence signals in the subicular 
field in slices loaded with the Ca2+ indicator Oregon Green BAPTA-1. Stimulus-
induced presynaptic Ca2+ transients were studied during pharmacological blockade 
of glutamatergic and GABAergic transmission (Liotta et al, 2012, Fig. S7). Activation 
of D1/D5Rs with the agonist SKF38393 resulted in a marked increase of stimulus-
induced Ca2+ transients exclusively in MK-801-treated rats and this was prevented 
by co-application of the LTCC blocker nifedipine (control+SKF38393: 99.82±1.15% 
of baseline, n=6; MK-801+SKF38393: 108.77±3.48% of baseline, n=9, p<0.05; MK-
801+SKF38393+nifedipine: 102.12±4.86% of baseline, n=6, Fig. 5e). These results 
indicate that LTCCs contribute to the D1/D5R-induced increase in presynaptic Ca2+ 
levels in MK-801-treated animals. 
 
Discussion 
 
The present study aimed to investigate LTP of hippocampal output structures after 
systemic NMDAR antagonism by single MK-801 administration. In control tissue, 
subicular LTP is NMDAR-dependent (Aoto et al, 2013; Wozny et al, 2008a, 2008b). 
In MK-801-treated rats, we found a presynaptic late-onset LTP restricted to subicular 
pyramidal cells. This LTP requires activation of D1/D5Rs, but not D2Rs, and the AC-
cAMP-PKA cascade. It is modulated by LTCCs and independent of postsynaptic 
Ca2+ signaling (for summary see Fig. 5f). Though the expression of LTP (>5 min after 
stimulation) is NMDAR-independent, the initial phase (<5 min after stimulation) was 
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dependent on the (co-)activation of NMDAR and D1/D5R. Interestingly, the 
persistence of protein synthesis-dependent late-LTP (beyond 4 hours post induction) 
at SC-CA1 synapses requires the co-activation of NMDAR and D1/D5R (Navakkode 
et al, 2007; O’Carroll and Morris, 2004). However, we only investigated early-LTP 
(30 min post induction). Evidently, at least during this phase of LTP, there are 
alternative NMDAR-independent pathways that can lead to the D1/D5R-induced LTP 
at CA1-SUB synapses in MK-801-treated rats. 
Several lines of evidence support a presynaptic expression of this LTP. LTP was 
accompanied by changes in PPI, transmission failure rates and the CV indicating an 
increase in presynaptic transmitter release. LTP was independent of postsynaptic 
Ca2+ and Ca2+ fluorescence recordings demonstrated a LTCC-modulated rise in Ca2+ 
signals after D1/D5R activation. 
As we found no difference in the extent of forskolin-induced enhancement of EPSCs 
between control and MK-801 animals, alterations upstream of the AC-cAMP-PKA 
cascade or AC-independent mechanisms have to be considered. G-protein-mediated 
signaling can modulate transmitter release by regulating presynaptic Ca2+ influx and 
cAMP levels. A priming effect of cAMP in concert with Ca2+ has been suggested to 
interfere with the recruitment of synaptic vesicles during repetitive activity (Yao and 
Sakaba, 2010). This mechanism is compatible with the assumption that G-protein-
coupled D1/D5Rs can regulate the efficacy of synaptic vesicle exocytosis. It might be 
crucial in preventing depletion of presynaptic vesicular glutamate stores under 
conditions of sustained activity, e.g. repetitive HFS during LTP induction. 
In MK-801-treated animals, LTCCs contribute to the increased Ca2+ levels upon 
D1/D5R stimulation and D1/D5R-induced LTP expression. This could be due to 
increased LTCC expression, changes in subcellular localization or enhanced 
 15
functional properties of pre-existing LTCCs. Given that D1/D5Rs are positively 
coupled to the AC-cAMP-PKA pathway, an enhanced LTCC efficacy following 
D1/D5R activation by a PKA-dependent mechanism seems reasonable (Fourcaudot 
et al, 2008). Functional channel modification by proteins interacting with LTCCs like 
presynaptic active zone components should also be considered (Fourcaudot et al, 
2008). LTCCs are known to play a crucial role in controlling neuronal excitability, 
synaptic plasticity and gene expression throughout the nervous system (Calin-
Jageman and Lee, 2008). For example, a LTCC-dependent increase in glutamate 
release underlies the presynaptic LTP of cortical inputs to the lateral amygdala 
(Fourcaudot et al, 2009). The brain-specific pore-forming α1C subunit of the LTCC, 
CaV1.2, is expressed pre- and postsynaptically in the hippocampus (Tippens et al, 
2008). Mice with a hippocampus-specific knockout of Cacna1c encoding for CaV1.2 
show a selective loss of protein synthesis-dependent, NMDAR-independent SC-CA1 
late-phase LTP (Moosmang et al, 2005). Interestingly, recent clinical genetic 
association studies have established an association of polymorphisms in the α1C 
subunit of the LTCC gene (CACNA1C) and schizophrenia (Bhat et al, 2012). Thus, 
LTCCs may link D1/D5R function and the altered expression of LTP after psychotic 
states. In clinical trials, LTCC blockers led to conflicting results, though cognition 
improving effects were reported in schizophrenic patients and ketamine-induced 
psychosis (Hollister and Trevino, 1999; Krupitsky et al, 2001). Of course, other 
substances and pathways like the therapeutic merits of the nitric oxide donor sodium 
nitroprusside should also be recognized as it has been shown to block the 
phencyclidine-induced activation of c-fos (Bujas-Bobanovic et al, 2000; Hallak et al, 
2013). 
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Hippocampal dysfunction in and after psychosis has been suggested to include 
subfield-specific alterations in synaptic plasticity (Tamminga et al, 2012; 
Wiescholleck and Manahan-Vaughan, 2013; Wöhrl et al, 2007). The CA1 and SUB 
act as major relay stations in the hippocampus-VTA loop. The enhanced LTP at 
CA1-SUB synapses following systemic NMDAR antagonism is expected to result in 
an increased subicular output. This could lead to a positive feedback in the 
hippocampus-VTA loop and augmentation of the DA system. This mechanism is in 
line with the hippocampal hyperactivity model in which a hyperactive ventral 
hippocampus drives a DA hyperfunction and results in aberrant DA neuron signaling 
(Lodge and Grace, 2007). This might be a key factor in the development of 
pathological changes in dopaminergic circuits. While commonly used antipsychotics 
predominantly act on D2Rs, D1/D5Rs have been implicated in cognitive function 
(e.g. working memory). The encoding of novel information relies on the time-locked 
release of DA and D1/D5R activation in the hippocampus (Li et al, 2003). Insufficient 
or excessive D1/D5R stimulation seems to be deleterious to cognitive function 
(Lisman and Otmakhova, 2001; Williams and Castner, 2006). 
Lasting hippocampus-dependent deficits after a single application of NMDAR 
antagonists including MK-801 that persisted for up to months have been reported 
(Lukoyanov and Paula-Barbosa, 2000; Manahan-Vaughan et al, 2008; Wiescholleck 
and Manahan-Vaughan, 2013; Wozniak et al, 1996). The enhanced subicular LTP 
occurred one hour after MK-801-treatment and lasted for about one week. This time-
locked correlation suggests that the observed subicular plasticity could contribute to 
the MK-801-induced hippocampus-dependent behavioral deficits in the drug-
withdrawn state. However, adaptive coping mechanisms including a compensatory 
upregulation of LTCC function after temporary NMDAR-antagonism have to be 
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considered as well. Besides that, the enhanced LTP could be attributed to the 
reported potent antidepressant effects of acute NMDAR antagonist administration 
(for a review see Browne and Lucki, 2013). Using GluN2B-selective antagonists 
which display antidepressant but lack the psychotomimetic effects might help to 
clarify this issue. 
 
In summary, the present study is the first to reveal a region-specific presynaptic form 
of LTP in the hippocampus that is induced by activation of D1/D5Rs and modulated 
by LTCCs and NMDAR after drug-induced psychosis. Thereby, our findings may 
provide a cellular mechanism how NMDAR antagonism can lead to an enhanced 
hippocampal output causing activation of the hippocampus-VTA-loop and overdrive 
of the dopamine system. 
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Figure Legends 
 
Fig. 1: Systemic MK-801 application leads to subicular late-onset LTP. (a-c) 
LTP in CA1 following strong HFS (4x 100 pulses at 100 Hz) is significantly impaired 
in MK-801-treated rats (control: 100 Hz n=8, 40 Hz n=7, MK-801: 100 Hz n=8, 40 Hz 
n=7, nonpaired t-test, **p<0.01). (d-f) Attenuated HFS (10 pulses at 40 Hz) induces 
LTP at CA1-SUB synapses selectively in MK-801-treated rats (control: 100 Hz n=11, 
40 Hz n=10, MK-801: 100 Hz n=9, 40 Hz n=9, non-paired t-test, ***p<0.001). (a-c, d-
f) Scale bars of EPSPs: 5 mV, 25 ms. (c+f) Columns represent mean±SEM after 
electrical stimulation protocol. See also Fig. S1, Table S1. 
 
Fig. 2: LTP in MK-801 treated rats is induced by activation of D1/D5R. (a) 
Application of the NMDAR antagonist AP5 reveals an initial NMDAR-dependent 
component (min 10-15) but fails to block LTP (n=7). (b) The D2R antagonist sulpiride 
(n=9) does not block the induction of LTP in MK-801-treated rats. (c) Blocking 
D1/D5R with the D1/D5R antagonist SCH23390 before electrical stimulation 
prevents LTP (n=8). (d) Blocking D1/D5R after LTP induction does not prevent LTP 
expression (n=7). (a-d) MK-801 data taken from Fig. 1e is replotted for comparison. 
(e) Bath-application of SCH23390 does not affect baseline EPSP amplitudes in MK-
801-treated rats (n=6). (f) Normalized sample traces of EPSP responses to HFS (10 
pulses at 40 Hz) in MK-801-treated rats with or without D1/D5R blockade, scale bar: 
25 ms. (g) Short-term depression of synaptic responses during sustained activity 
increases when D1/D5Rs are blocked (MK-801: n=9, MK-801+SCH23390: n=8, non-
paired t-test, **p<0.01, *p<0.05). (h) Bath-application of the D1/D5R agonist 
SKF38393 enhances EPSP amplitudes at various concentrations only in MK-801-
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treated rats, non-paired t-test, 10 µM: control: n=6, MK-801: n=8 *p<0.05, 30 µM: 
control: n=9, MK-801: n=7 **p<0.01). Scale bars of EPSPs: 2.5 mV, 25 ms. (i) PPI 
decreases after D1/D5R agonist-induced LTP in MK-801-treated rats (paired t-test, 
*p<0.05). Scale bar of paired-pulse recordings: amplitude scaled to first pulse of 
SKF38393, 25 ms. Columns in (h, i) represent mean±SEM. See also Fig. S2, S3, S6. 
 
Fig. 3: LTP in MK-801 treated rats is expressed presynaptically and is 
independent of postsynaptic Ca2+. (a) PPI decreases after electrical induction of 
LTP in MK-801-treated rats (paired t-test, *p<0.05). Points depict mean value of 
single neurons before and after LTP induction. Scale bar of paired-pulse recordings: 
amplitude scaled to first pulse of LTP, 25 ms. (b) LTP in MK-801-treated rats is 
associated with a decrease in failure rate of minimal stimulation, points represent 
single neurons (Wilcoxon test, **p<0.01). (c) Postsynaptic dialysis with the Ca2+ 
buffer BAPTA fails to prevent the expression of LTP in MK-801-treated rats (one-way 
ANOVA F(2,20)=9.974, ***p<0.001, post-hoc Dunnett’s test: MK-801 n=7 ***p<0.001, 
MK-801+BAPTA n=8 *p<0.05, control n=8), scale bars of EPSCs: 100 pA, 25 ms. 
See also Fig. S4. 
 
Fig. 4: Blockade of D1/D5Rs decreases mEPSC frequency at CA1-SUB 
synapses in MK-801-treated rats. (a) Subicular pyramidal cells are innervated by 
D1R-positive terminals. Confocal images of a biocytin-filled dendrite from a subicular 
bursting cell in control and MK-801-treated rat (i+v). D1R (ii+vi), and vGluT1 (iii+vii) 
immunohistochemical staining in the same area. (iv) D1R- and vGluT1-
immunopositive presynaptic terminal (arrow) ending onto the distal biocytin-filled 
dendritic shaft seen in (i). (viii) D1R- and vGluT1-immunopositive presynaptic 
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terminal (arrow) terminating onto the distal biocytin-filled dendritic spine seen in (v). 
Scale bar: 2 µm in control and 5 µm in MK-801. (b) Same as in (a) but stained 
against D5R. (iv+viii) D5R- and vGluT1-immunopositive presynaptic terminal (arrow) 
terminating onto the proximal biocytin-filled dendritic spine seen in (i) and (v). Scale 
bar: 5 µm in (i) to (viii). (c+d) D1/D5R blockade reduces mEPSC frequency but not 
amplitude in MK-801-treated rats (paired t-test *p<0.05), points represent single 
experiments, columns represent mean±SEM, scale bars: 10 pA, 250 ms. (e+f) 
Cumulative histograms of inter-event intervals (MK-801: Kolmogorov-Smirnov test 
*p<0.05). 
 
Fig. 5: LTP in MK-801-treated rats is mediated by the AC-cAMP-PKA cascade 
and modulated by LTCCs. (a) Preincubation with a PKA inhibitor prevents LTP 
(n=6). (b) Activation of AC enhances subicular EPSC amplitudes in both animal 
groups (control: n=6, MK-801: n=6), scale bars: 100 pA, 25 ms. (c+d) Blocking 
LTCCs before (n=9) or after (n=9) LTP induction impairs LTP expression. (a, c, d,) 
MK-801 data taken from Fig. 1e is replotted for comparison. (e) D1/D5R activation 
leads to an increased stimulus-induced Ca2+ fluorescence signal in MK-801-treated 
rats in absence of LTCC blockage (paired t-test, *p<0.05), columns represent 
mean±SEM, scale bars of sample fluorescence recordings: 5% ∆F/F0, 1 s, arrows 
indicate start of stimulus (20 pulses at 20 Hz). (f) Summary of changes in synaptic 
strength following attenuated HFS (10 pulses at 40 Hz) for the different experimental 
groups (Kruskal-Wallis H-test (H(9)=53.35, p<0.0001) followed by post-hoc Dunn’s 
test). Control and MK-801 data taken from Fig. 1f is replotted for comparison. 
Columns represent mean±SEM after electrial stimulation protocol. See also Fig. S5, 
S7. 
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